PTPN2, a potential therapeutic target for type 1 diabetes?

被引：2
|
作者：
Liu, Shan-Shan [1 ]
Lou, Ji-Quan [1 ]
Ding, Ye [1 ]
机构：
[1] Shanghai Pudong Inst Hlth Dev, Dept Hlth Evaluat, Shanghai, Peoples R China
来源：
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 2014年 / 58卷 / 09期
关键词：
BETA-CELL APOPTOSIS; CANDIDATE GENE;
D O I：
10.1590/0004-2730000003561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：978 / 979
页数：2
相关论文
共 50 条
  • [1] A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes
    Laura Espino-Paisan
    Hermenegildo de la Calle
    Miguel Fernández-Arquero
    Maria Ángeles Figueredo
    Emilio G. de la Concha
    Elena Urcelay
    Jose Luis Santiago
    Immunogenetics, 2011, 63 : 255 - 258
  • [2] A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes
    Espino-Paisan, Laura
    de la Calle, Hermenegildo
    Fernandez-Arquero, Miguel
    Angeles Figueredo, Maria
    de la Concha, Emilio G.
    Urcelay, Elena
    Luis Santiago, Jose
    IMMUNOGENETICS, 2011, 63 (04) : 255 - 258
  • [3] Genetic Variants of PTPN2 Gene in Chinese Children with Type 1 Diabetes Mellitus
    Peng, Hui
    Li, Jiamei
    Chen, Xiaoyun
    Zhou, Xiao
    Zhu, Weiwei
    Li, Feng
    MEDICAL SCIENCE MONITOR, 2015, 21 : 2653 - 2658
  • [4] PTPN2 gene polymorphisms are associated with type 1 diabetes mellitus in Brazilian subjects?
    Rheinheimer, Jakeline
    Canani, Luis Henrique
    Crispim, Daisy
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (09) : 980 - 981
  • [5] Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease
    Sharp, Robert C.
    Abdulrahim, Muna
    Naser, Ebraheem S.
    Naser, Saleh A.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2015, 5
  • [6] Novel polymorphism in the PTPN2 gene is associated with type 1 diabetes mellitus in Russian patients
    Seregin, Y. A.
    Lavrikova, E. Y.
    Nikitin, A. G.
    Zilberman, L. I.
    Kuraeva, T. L.
    Nosikov, V. V.
    DIABETOLOGIA, 2009, 52 : S111 - S112
  • [7] MBL, a potential therapeutic target for type 1 diabetes?
    Liu, Shan-Shan
    Lou, Ji-Quan
    Ding, Ye
    MOLECULAR IMMUNOLOGY, 2015, 63 (02) : 603 - 603
  • [8] Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes
    Okuno, M.
    Ayabe, T.
    Yokota, I.
    Musha, I.
    Shiga, K.
    Kikuchi, T.
    Kikuchi, N.
    Ohtake, A.
    Nakamura, A.
    Nakabayashi, K.
    Okamura, K.
    Momozawa, Y.
    Kubo, M.
    Suzuki, J.
    Urakami, T.
    Kawamura, T.
    Amemiya, S.
    Ogata, T.
    Sugihara, S.
    Fukami, M.
    DIABETIC MEDICINE, 2018, 35 (03) : 376 - 380
  • [9] TRPV1: A Potential Therapeutic Target in Type 2 Diabetes and Comorbidities?
    Gram, Dorte X.
    Holst, Jens J.
    Szallasi, Arpad
    TRENDS IN MOLECULAR MEDICINE, 2017, 23 (11) : 1002 - 1013
  • [10] Glucagon antagonism as a potential therapeutic target in type 2 diabetes
    Bagger, J. I.
    Knop, F. K.
    Holst, J. J.
    Vilsboll, T.
    DIABETES OBESITY & METABOLISM, 2011, 13 (11): : 965 - 971
12345